MedTrace Logo

Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study

NCT03056612 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1314

Last updated 2019-04-12

No results posted yet for this study

Summary

The aim of this study is to assess prospectively the critical period prior to the development of Acute-on-Chronic Liver Failure (ACLF) (1), to uncover mechanistic and pathophysiological processes associated with the development and clinical course of ACLF (2) and to identify the precipitating events of ACLF (3).

Conditions

  • Liver Cirrhosis With Acute Decompensation

Interventions

OTHER

Observation protocol

The whole cohort will be followed for 3 months, while Group 1 will be followed more closely.

Sponsors & Collaborators

  • Jonel Trebicka

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-31
Primary Completion
2018-07-31
Completion
2018-10-31

Countries

  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Portugal
  • Slovakia
  • Spain
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03056612 on ClinicalTrials.gov